+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Oral Antibiotics Market (2022-2027) by Class, Action Mechanism, Application, Drug Origin, Activity Spectrum, Drug Type, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon

    Report

  • 183 Pages
  • May 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5636012

Oral Antibiotics are rapidly losing ground in the fight against bacteria

The Global Oral Antibiotics Market is estimated to be USD 20.42 Bn in 2022 and is expected to reach USD 23.22 Bn by 2027, growing at a CAGR of 2.6%.



Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Oral Antibiotics Market is segmented based on Class, Action Mechanism, Application, Drug Origin, Activity Spectrum, Drug Type, and Geography.
  • By Class, the market is classified into Beta Lactam and Beta Lactamase Inhibitors, Quinolones, Macrolides, and Others.
  • By Action Mechanism, the market is classified into Cell Wall Synthesis Inhibitors, Mycolic Acid Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Protein Synthesis Inhibitors, and Other Mechanisms.
  • By Application, the market is classified into Community-Acquired Respiratory Tract Infections (CARTIs), Urinary Tract Infections (UTIs), and Others.
  • By Drug Origin, the market is classified into Natural, Semisynthetic, and Synthetic.
  • By Activity Spectrum, the market is classified into Broad-spectrum antibiotic, and Mid/Narrow-spectrum antibiotic.
  • By Drug Type, the market is classified into Branded and Generics.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, Astellas Pharma, AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Company, Cipla Inc., Dr. Reddy’s Laboratories Ltd., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Oral Antibiotics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the Global Oral Antibiotics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Oral Antibiotics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Oral Antibiotics Market

What is the estimated value of the Global Oral Antibiotics Market?

The Global Oral Antibiotics Market was estimated to be valued at $20.42 Billion in 2022.

What is the growth rate of the Global Oral Antibiotics Market?

The growth rate of the Global Oral Antibiotics Market is 2.6%, with an estimated value of $23.22 Billion by 2027.

What is the forecasted size of the Global Oral Antibiotics Market?

The Global Oral Antibiotics Market is estimated to be worth $23.22 Billion by 2027.

Who are the key companies in the Global Oral Antibiotics Market?

Key companies in the Global Oral Antibiotics Market include Abbott Laboratories, Astellas Pharma, AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Company, Cipla Inc Dr. Reddy’s Laboratories Ltd Eli Lilly and Company, F. Hoffmann, La Roche Ltd Gilead Sciences, Inc GlaxoSmithKline plc. and Mayne Pharma Group Ltd Melinta Therapeutics LLC.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increase in consumption in Developing Countries
4.1.2 Increasing Prevalence of Infectious Diseases
4.2 Restraints
4.2.1 Development of Antibiotic Resistance
4.2.2 Longer Time consumption for Approval
4.3 Opportunities
4.3.1 Discovery of Advanced Therapies to Treat Antibiotic-Resistance
4.3.2 Development of Novel Approaches
4.4 Challenges
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Oral Antibiotics Market, By Class
6.1 Introduction
6.2 Beta Lactam and Beta Lactamase Inhibitors
6.2.1 Penicillin
6.2.2 Cephalosporin
6.2.3 Others
6.3 Quinolones
6.4 Macrolides
6.5 Others
7 Global Oral Antibiotics Market, By Action Mechanism
7.1 Introduction
7.2 Cell Wall Synthesis Inhibitors
7.3 Mycolic Acid Inhibitors
7.4 DNA Synthesis Inhibitors
7.5 RNA Synthesis Inhibitors
7.6 Protein Synthesis Inhibitors
7.7 Other Mechanisms
8 Global Oral Antibiotics Market, By Application
8.1 Introduction
8.2 Community-Acquired Respiratory Tract Infections (CARTIs)
8.2.1 Upper Respiratory Tract Infections (URTI)
8.2.2 Lower Respiratory Tract Infections (LRTIs)
8.3 Urinary Tract Infections (UTIs)
8.4 Dental
8.4.1 Monotherapy
8.4.2 Combination
8.5 Others
9 Global Oral Antibiotics Market, By Drug Origin
9.1 Introduction
9.2 Natural
9.3 Semisynthetic
9.4 Synthetic
10 Global Oral Antibiotics Market, By Activity Spectrum
10.1 Introduction
10.2 Broad-spectrum antibiotic
10.3 Mid/Narrow-spectrum antibiotic
11 Global Oral Antibiotics Market, By Drug Type
11.1 Introduction
11.2 Branded
11.3 Generics
12 Americas’ Oral Antibiotics Market
12.1 Introduction
12.2 Argentina
12.3 Brazil
12.4 Canada
12.5 Chile
12.6 Colombia
12.7 Mexico
12.8 Peru
12.9 United States
12.10 Rest of Americas
13 Europe’s Oral Antibiotics Market
13.1 Introduction
13.2 Austria
13.3 Belgium
13.4 Denmark
13.5 Finland
13.6 France
13.7 Germany
13.8 Italy
13.9 Netherlands
13.10 Norway
13.11 Poland
13.12 Russia
13.13 Spain
13.14 Sweden
13.15 Switzerland
13.16 United Kingdom
13.17 Rest of Europe
14 Middle East and Africa’s Oral Antibiotics Market
14.1 Introduction
14.2 Egypt
14.3 Israel
14.4 Qatar
14.5 Saudi Arabia
14.6 South Africa
14.7 United Arab Emirates
14.8 Rest of MEA
15 APAC’s Oral Antibiotics Market
15.1 Introduction
15.2 Australia
15.3 Bangladesh
15.4 China
15.5 India
15.6 Indonesia
15.7 Japan
15.8 Malaysia
15.9 Philippines
15.10 Singapore
15.11 South Korea
15.12 Sri Lanka
15.13 Thailand
15.14 Taiwan
15.15 Rest of Asia-Pacific
16 Competitive Landscape
16.1 Competitive Quadrant
16.2 Market Share Analysis
16.3 Strategic Initiatives
16.3.1 M&A and Investments
16.3.2 Partnerships and Collaborations
16.3.3 Product Developments and Improvements
17 Company Profiles
17.1 Abbott Laboratories
17.2 Astellas Pharma
17.3 AstraZeneca Plc
17.4 Bayer AG
17.5 Bristol Myers Squibb Company
17.6 Cipla Inc
17.7 Dr. Reddy’s Laboratories Ltd
17.8 Eli Lilly and Company
17.9 F. Hoffmann-La Roche Ltd
17.10 Gilead Sciences, Inc
17.11 GlaxoSmithKline plc.
17.12 Johnson & Johnson Services, Inc (Janssen Pharmaceuticals)
17.13 Mayne Pharma Group Ltd
17.14 Melinta Therapeutics LLC
17.15 Merck & Co., Inc
17.16 Novartis AG
17.17 Pfizer Inc
17.18 Sanofi
17.19 Sun Pharmaceutical Industries Ltd
18 Appendix
18.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • Astellas Pharma
  • AstraZeneca Plc
  • Bayer AG
  • Bristol Myers Squibb Company
  • Cipla Inc Dr. Reddy’s Laboratories Ltd Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd Gilead Sciences, Inc GlaxoSmithKline plc.
  • Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)
  • Mayne Pharma Group Ltd Melinta Therapeutics LLC
  • Merck & Co., Inc
  • Novartis AG
  • Pfizer Inc Sanofi
  • Sun Pharmaceutical Industries Ltd.